O. Donnay

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

Jacobo Rogado, J.M. Sánchez-Torres, Nuria Romero-Laorden et al. · European Journal of Cancer · 2019 · 261 citations

Life Sciences, Immunology, Oncology +17

SEOM clinical guidelines on nutrition in cancer patients (2018)

R. de las Peñas, Margarita Majem, Javier Pérez-Altozano et al. · Clinical & Translational Oncology · 2019 · 118 citations · Full text

Agriculture, Nutrition, Oncology +17

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

A systemic inflammation response index (SIRI) correlates with survival and predicts oncological outcome for mFOLFIRINOX therapy in metastatic pancreatic cancer

Vilma Pacheco-Barcía, Rebeca Mondéjar Solís, T. France et al. · Pancreatology · 2019 · 81 citations

Medicine, Immunology, Oncology +15

Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy

Paula Jiménez‐Fonseca, Caterina Calderón, Raquel Hernández et al. · Clinical & Translational Oncology · 2018 · 60 citations

Medicine, Oncology, Psychiatry +12